TScan Therapeutics
Developing T-cell receptor-based therapies for cancer and autoimmune diseases.
Company facts
- Founded
- 2018
- Employees
- 171
- Headquarters
- United States
- Type
- Public
- Listed
- Nasdaq: TCRX
Developing T-cell receptor-based therapies for cancer and autoimmune diseases.
Company facts